Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc
Bullboard Posts
User Avatar Image
(2)
•••
Comment by labumbaon Oct 19, 2009 9:40am
455 Views
Post# 16399380

RE: Lux Biosciences Completes $50 Million Series B

RE: Lux Biosciences Completes $50 Million Series BSo all this time is money..... Lux now has the money to go head in full trotle to get this drug to the market and ISA will get the milestone if it is approved by FDA.....
the priorty review ( about 6 month duration ) has not been started yet....still the whole picture is quite promising......indeed, this is extremely good upate for us from Lux
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities